📰 Nasdaq Blu News
Nasdaq Blu News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Nasdaq Blu. Real-time updates on events, politics, business and more.
May 22, 2023
Sectoral Asset Management Inc. grew its holdings in shares of BELLUS Health Inc. (NASDAQ:BLU – Get Rating) by 8.9% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 669,029 shares of the company’s stock after buying an additional 54,600 shares during the […]
May 15, 2023
BELLUS Health Inc. (NASDAQ:BLU – Get Rating) saw a large decline in short interest in the month of April. As of April 30th, there was short interest totalling 7,200,000 shares, a decline of 36.5% from the April 15th total of 11,330,000 shares. Based on an average trading volume of 4,050,000 shares, the days-to-cover ratio is […]
May 12, 2023
BELLUS Health Inc. (NASDAQ:BLU – Get Rating) was the target of a large drop in short interest in April. As of April 30th, there was short interest totalling 7,200,000 shares, a drop of 36.5% from the April 15th total of 11,330,000 shares. Based on an average trading volume of 4,050,000 shares, the days-to-cover ratio is […]
May 12, 2023
BELLUS Health Inc. (NASDAQ:BLU – Get Rating) was the recipient of a large decline in short interest in April. As of April 30th, there was short interest totalling 7,200,000 shares, a decline of 36.5% from the April 15th total of 11,330,000 shares. Based on an average daily trading volume, of 4,050,000 shares, the days-to-cover ratio […]
May 3, 2023
BELLUS Health Inc. (NASDAQ:BLU – Get Rating) was the target of a large increase in short interest during the month of April. As of April 15th, there was short interest totalling 11,330,000 shares, an increase of 5.5% from the March 31st total of 10,740,000 shares. Based on an average trading volume of 3,660,000 shares, the […]
April 22, 2023
BELLUS Health (NASDAQ:BLU – Get Rating) and GH Research (NASDAQ:GHRS – Get Rating) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, earnings, analyst recommendations, institutional ownership, risk, profitability and dividends. Insider and Institutional Ownership 90.1% of BELLUS Health shares […]
April 22, 2023
Lifesci Capital lowered shares of BELLUS Health (NASDAQ:BLU – Get Rating) from an outperform rating to a market perform rating in a report released on Tuesday morning, Marketbeat.com reports. Several other analysts have also recently weighed in on the company. Evercore ISI cut BELLUS Health to an outperform rating in a report on Tuesday. HC […]
April 21, 2023
Evercore ISI lowered shares of BELLUS Health (NASDAQ:BLU – Get Rating) to an outperform rating in a research report report published on Tuesday morning, The Fly reports. A number of other research analysts have also recently weighed in on the company. HC Wainwright restated a buy rating and issued a $20.00 price target on shares […]
April 19, 2023
BELLUS Health (NASDAQ:BLU – Get Rating) was downgraded by stock analysts at Royal Bank of Canada from an “outperform” rating to a “sector perform” rating in a report issued on Tuesday, The Fly reports. BLU has been the subject of a number of other research reports. HC Wainwright reiterated a “buy” rating and set a […]
April 18, 2023
BELLUS Health Inc. (NASDAQ:BLU – Get Rating) shares reached a new 52-week high during trading on Tuesday . The stock traded as high as $14.43 and last traded at $14.43, with a volume of 67857446 shares changing hands. The stock had previously closed at $7.26. Analyst Ratings Changes Several equities analysts have issued reports on […]